Search Results

We hope you find what you’re looking for. You can email us if you need additional help.

Optimi Health Provides Corporate Update

VANCOUVER, BC – May 10, 2024 – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a leading Health Canada licensed GMP psychedelics pharmaceutical manufacturer, specializing in controlled substances such as botanical psilocybin and MDMA, announces

Read More »

Products do not contain psilocybin

Get news & updates directly to your inbox.
Interested In Optimi? Let's Talk.